{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:51:15Z","timestamp":1794135075589,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R754"],"award-info":[{"award-number":["RSPD2025R754"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R342"],"award-info":[{"award-number":["PNURSP2025R342"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97786-7","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T09:59:51Z","timestamp":1744970391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In Silico and in vitro evaluation of the anticancer effect of a 1,5-Benzodiazepin-2-One derivative (3b) revealing potent dual inhibition of HER2 and HDAC1"],"prefix":"10.1038","volume":"15","author":[{"given":"Nada S.","family":"Al-Theyab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H.","family":"Bakheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Lahmidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Mufadhe","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awadh M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Azzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Mokhtar","family":"Essassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Mague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hefnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Mater","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwag S.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"97786_CR1","first-page":"10","volume":"75","author":"RL Siegel Mph","year":"2025","unstructured":"Siegel Mph, R. L. et al. Cancer Stat. 2025 CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"Cancer Stat. 2025 CA Cancer J. Clin."},{"key":"97786_CR2","doi-asserted-by":"publisher","first-page":"104398","DOI":"10.1016\/j.bspc.2022.104398","volume":"80","author":"S Maurya","year":"2023","unstructured":"Maurya, S. et al. A review on recent developments in cancer detection using machine learning and deep learning models. Biomed. Signal. Process. Control. 80, 104398 (2023).","journal-title":"Biomed. Signal. Process. Control"},{"key":"97786_CR3","doi-asserted-by":"publisher","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"T Emran","year":"2022","unstructured":"Emran, T. et al. Multidrug resistance in cancer: Understanding molecular mechanisms, Immunoprevention and therapeutic approaches. Front. Oncol. 12, 891652 (2022).","journal-title":"Front. Oncol."},{"key":"97786_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.breast.2022.02.003","volume":"62","author":"CH Barrios","year":"2022","unstructured":"Barrios, C. H. Global challenges in breast cancer detection and treatment. Breast 62, S3\u2013S6 (2022).","journal-title":"Breast"},{"key":"97786_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1200\/EDBK_323523","volume":"41","author":"RU Osarogiagbon","year":"2021","unstructured":"Osarogiagbon, R. U., Sineshaw, H. M., Unger, J. M., Acu\u00f1a-Villaordu\u00f1a, A. & Goel, S. Immune-Based cancer treatment: addressing disparities in access and outcomes. Am. Soc. Clin. Oncol. Educ. Book. Am. Soc. Clin. Oncol. Annu. Meet. 41, 66\u201378 (2021).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book. Am. Soc. Clin. Oncol. Annu. Meet"},{"key":"97786_CR6","first-page":"610","volume":"59","author":"AS Alanazi","year":"2023","unstructured":"Alanazi, A. S., Mirgany, T. O., Alsfouk, A. A., Alsaif, N. A. & Alanazi, M. M. Antiproliferative activity, multikinase Inhibition, Apoptosis- inducing effects and molecular Docking of novel Isatin\u2013Purine hybrids. Med 59, 610 (2023).","journal-title":"Med"},{"key":"97786_CR7","doi-asserted-by":"crossref","unstructured":"Debela, D. T. et al. New approaches and procedures for cancer treatment: current perspectives. SAGE Open. Med. 9, (2021).","DOI":"10.1177\/20503121211034366"},{"key":"97786_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-023-01275-4","volume":"28","author":"R Mohi-ud-din","year":"2023","unstructured":"Mohi-ud-din, R. et al. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. Eur. J. Med. Res. 28, 1\u201335 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"97786_CR9","doi-asserted-by":"crossref","unstructured":"Alessy, S. A. et al. Cancer research challenges and potential solutions in Saudi Arabia: A qualitative discussion group study. JCO Glob Oncol. 10, (2024).","DOI":"10.1200\/GO.23.00189"},{"key":"97786_CR10","doi-asserted-by":"crossref","unstructured":"Shi, M. Q. et al. Advances in targeting histone deacetylase for treatment of solid tumors. J. Hematol. Oncol. 17, 1\u201320 (2024). (2024).","DOI":"10.1186\/s13045-024-01551-8"},{"key":"97786_CR11","doi-asserted-by":"crossref","unstructured":"Zhu, K. et al. HER2-targeted therapies in cancer: a systematic review. Biomark. Res. 12, 1\u201317 (2024). (2024).","DOI":"10.1186\/s40364-024-00565-1"},{"key":"97786_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/13895575113139990081","volume":"14","author":"R Gill","year":"2014","unstructured":"Gill, R. et al. Recent development in [1,4]Benzodiazepines as potent anticancer agents: A review. Mini-Reviews Med. Chem. 14, 229\u2013256 (2014).","journal-title":"Mini-Reviews Med. Chem."},{"key":"97786_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/cpdd.667","volume":"8","author":"HK Greenblatt","year":"2019","unstructured":"Greenblatt, H. K. & Greenblatt, D. J. Designer benzodiazepines: A review of published data and public health significance. Clin. Pharmacol. Drug Dev. 8, 266\u2013269 (2019).","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"97786_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxics9020025","volume":"9","author":"E Sanabria","year":"2021","unstructured":"Sanabria, E., Cuenca, R. E., Esteso, M. \u00c1. & Maldonado, M. Benzodiazepines: their use either as essential medicines or as toxics substances. Toxics 9, 1\u201318 (2021).","journal-title":"Toxics"},{"key":"97786_CR15","doi-asserted-by":"publisher","first-page":"104010","DOI":"10.1016\/j.bioorg.2020.104010","volume":"101","author":"R Verma","year":"2020","unstructured":"Verma, R. et al. Design, synthesis and neuropharmacological evaluation of new 2,4-disubstituted-1,5-benzodiazepines as CNS active agents. Bioorg. Chem. 101, 104010 (2020).","journal-title":"Bioorg. Chem."},{"key":"97786_CR16","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S0006-2952(99)00156-2","volume":"58","author":"J Nordenberg","year":"1999","unstructured":"Nordenberg, J., Fenig, E., Landau, M., Weizman, R. & Weizman, A. Effects of psychotropic drugs on cell proliferation and differentiation. Biochem. Pharmacol. 58, 1229\u20131236 (1999).","journal-title":"Biochem. Pharmacol."},{"key":"97786_CR17","first-page":"287","volume":"29","author":"OO Tolu-Bolaji","year":"2022","unstructured":"Tolu-Bolaji, O. O., Sojinu, S. O., Okedere, A. P. & Ajani, O. O. A review on the chemistry and Pharmacological properties of benzodiazepine motifs in drug design. Arab. J. Basic. Appl. Sci. 29, 287\u2013306 (2022).","journal-title":"Arab. J. Basic. Appl. Sci."},{"key":"97786_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.chembiol.2014.03.004","volume":"21","author":"SG Smith","year":"2014","unstructured":"Smith, S. G., Sanchez, R. & Zhou, M. M. Privileged Diazepine compounds and their emergence as bromodomain inhibitors. Chem. Biol. 21, 573 (2014).","journal-title":"Chem. Biol."},{"key":"97786_CR19","doi-asserted-by":"crossref","unstructured":"Wu, K. C., Liao, K. S., Yeh, L. R. & Wang, Y. K. Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics. Biomedicines 10, (2022).","DOI":"10.3390\/biomedicines10071589"},{"key":"97786_CR20","doi-asserted-by":"publisher","first-page":"111670","DOI":"10.1016\/j.ejmech.2019.111670","volume":"182","author":"Y Pang","year":"2019","unstructured":"Pang, Y. et al. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through Inhibition of tubulin polymerization in vitro and in vivo. Eur. J. Med. Chem. 182, 111670 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"97786_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/jm050956q","volume":"49","author":"JJ Wang","year":"2006","unstructured":"Wang, J. J. et al. Design, synthesis, and biological evaluation of pyrrolo[2,1-c][1,4] benzodiazepine and Indole conjugates as anticancer agents. J. Med. Chem. 49, 1442\u20131449 (2006).","journal-title":"J. Med. Chem."},{"key":"97786_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/187152009787047743","volume":"9","author":"L Cipolla","year":"2012","unstructured":"Cipolla, L., Araujo, A. C., Airoldi, C. & Bini, D. Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of Anti- tumour drugs. Anticancer Agents Med. Chem. 9, 1\u201331 (2012).","journal-title":"Anticancer Agents Med. Chem."},{"key":"97786_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bmc.2011.12.003","volume":"20","author":"A Kamal","year":"2012","unstructured":"Kamal, A. et al. Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents. Bioorg. Med. Chem. 20, 789\u2013800 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"97786_CR24","doi-asserted-by":"crossref","unstructured":"Odame, F. et al. Anticancer and Antimicrobial Activity of Some New 2,3-Dihydro-1,5-benzodiazepine Derivatives. Heteroat. Chem. (2023). (2023).","DOI":"10.1155\/2023\/3390122"},{"key":"97786_CR25","doi-asserted-by":"publisher","first-page":"14891","DOI":"10.1021\/acs.jmedchem.2c01431","volume":"65","author":"W Yu","year":"2022","unstructured":"Yu, W. et al. Identification of 1,4-Benzodiazepine-2,5-dione derivatives as potential protein synthesis inhibitors with highly potent anticancer activity. J. Med. Chem. 65, 14891\u201314915 (2022).","journal-title":"J. Med. Chem."},{"key":"97786_CR26","doi-asserted-by":"publisher","first-page":"101049","DOI":"10.1016\/j.rechem.2023.101049","volume":"6","author":"NG Fahad","year":"2023","unstructured":"Fahad, N. G., Imran, N. H., Kyhoiesh, K., Al-Hussainawy, M. K. & H. A. & Synthesis, anticancer for prostate cancer cells and antibacterial activity of new Diazepine derivatives. Results Chem. 6, 101049 (2023).","journal-title":"Results Chem."},{"key":"97786_CR27","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jksus.2019.12.002","volume":"32","author":"A Misra","year":"2020","unstructured":"Misra, A. et al. Synthesis, biological evaluation and molecular Docking of pyrimidine and Quinazoline derivatives of 1,5-benzodiazepine as potential anticancer agents. J. King Saud Univ. - Sci. 32, 1486\u20131495 (2020).","journal-title":"J. King Saud Univ. - Sci."},{"key":"97786_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/187152012800617713","volume":"12","author":"C Cortes Eduardo","year":"2012","unstructured":"Cortes Eduardo, C. et al. Anticancer activity and anti-inflammatory studies of 5-aryl-1,4-benzodiazepine derivatives. Anticancer Agents Med. Chem. 12, 611\u2013618 (2012).","journal-title":"Anticancer Agents Med. Chem."},{"key":"97786_CR29","doi-asserted-by":"crossref","unstructured":"da Silva, A. V., Meneghetti, S. M. P., Meneghetti, M. R. & Benzodiazepines Drugs with Chemical Skeletons Suitable for the Preparation of Metallacycles with Potential Pharmacological Activity. Mol. Vol. 26, Page 2796 26, 2796 (2021). (2021).","DOI":"10.3390\/molecules26092796"},{"key":"97786_CR30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/cryst13121693","volume":"13","author":"S Lahmidi","year":"2023","unstructured":"Lahmidi, S., Bakheit, A. H., Essassi, E. M., Mague, J. T. & Alanazi, M. M. X-ray crystal structure, Hirshfeld surface analysis, DFT, and anticancer effect of 3-Hydroxy-6-phenyl-1,5-benzodiazepin-2-one derivatives. Crystals 13, 1693 (2023).","journal-title":"Crystals"},{"key":"97786_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jsps.2023.05.003","volume":"31","author":"AS Alanazi","year":"2023","unstructured":"Alanazi, A. S., Mirgany, T. O., Alsaif, N. A., Alsfouk, A. A. & Alanazi, M. M. Design, synthesis, antitumor evaluation, and molecular Docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors. Saudi Pharm. J. 31, 989\u2013997 (2023).","journal-title":"Saudi Pharm. J."},{"key":"97786_CR32","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.3390\/molecules28155869","volume":"28","author":"MM Alanazi","year":"2023","unstructured":"Alanazi, M. M. & Alanazi, A. S. Novel 7-Deazapurine incorporating Isatin hybrid compounds as protein kinase inhibitors: design, synthesis, in Silico studies, and antiproliferative evaluation. Molecules 28, 5869 (2023).","journal-title":"Molecules"},{"key":"97786_CR33","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.3390\/molecules28145548","volume":"28","author":"A Altharawi","year":"2023","unstructured":"Altharawi, A. et al. Novel 2-Sulfanylquinazolin-4(3H)-one derivatives as Multi-Kinase inhibitors and apoptosis inducers: A synthesis, biological evaluation, and molecular Docking study. Molecules 28, 5548 (2023).","journal-title":"Molecules"},{"key":"97786_CR34","doi-asserted-by":"publisher","first-page":"101712","DOI":"10.1016\/j.jscs.2023.101712","volume":"27","author":"AAA Alotaibi","year":"2023","unstructured":"Alotaibi, A. A. A., Asiri, H. H., Rahman, A. F. M. M. & Alanazi, M. M. Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity. J. Saudi Chem. Soc. 27, 101712 (2023).","journal-title":"J. Saudi Chem. Soc."},{"key":"97786_CR35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/ph16091324","volume":"16","author":"AA Alotaibi","year":"2023","unstructured":"Alotaibi, A. A., Alanazi, M. M. & Rahman, A. F. M. M. Discovery of new Pyrrolo[2,3-d]pyrimidine derivatives as potential Multi-Targeted kinase inhibitors and apoptosis inducers. Pharmaceuticals 16, 1324 (2023).","journal-title":"Pharmaceuticals"},{"key":"97786_CR36","doi-asserted-by":"publisher","first-page":"138177","DOI":"10.1016\/j.molstruc.2024.138177","volume":"1309","author":"TO Mirgany","year":"2024","unstructured":"Mirgany, T. O., Rahman, A. F. M. M. & Alanazi, M. M. Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: promising candidates for anticancer therapy. J. Mol. Struct. 1309, 138177 (2024).","journal-title":"J. Mol. Struct."},{"key":"97786_CR37","doi-asserted-by":"crossref","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).","DOI":"10.1063\/5.0014475"},{"key":"97786_CR38","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1021\/ci200028n","volume":"51","author":"F Cheng","year":"2011","unstructured":"Cheng, F. et al. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers. J. Chem. Inf. Model. 51, 996\u20131011 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"97786_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"97786_CR40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"CHARMM","author":"BR Brooks","year":"2009","unstructured":"Brooks, B. R. et al. The biomolecular simulation program. J. Comput. Chem. 30. CHARMM, 1545\u20131614 (2009).","journal-title":"J. Comput. Chem. 30"},{"key":"97786_CR41","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/molecules28114271","volume":"28","author":"R Eskandrani","year":"2023","unstructured":"Eskandrani, R. et al. Targeting transcriptional CDKs 7, 8, and 9 with anilinopyrimidine derivatives as anticancer agents: design, synthesis, biological evaluation and in Silico studies. Molecules 28, 4271 (2023).","journal-title":"Molecules"},{"key":"97786_CR42","first-page":"6859","volume":"28","author":"AH Bakheit","year":"2023","unstructured":"Bakheit, A. H., Alkahtani, H. M. & Integrated Structural Functional, and ADMET analysis of 2-Methoxy-4,6-diphenylnicotinonitrile: the convergence of X-ray diffraction, molecular docking, dynamic simulations, and advanced computational insights. Mol. 2023. 28, 6859 (2023).","journal-title":"Mol. 2023"},{"key":"97786_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph"},{"key":"97786_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1874095200801020083","volume":"2","author":"M Rida","year":"2014","unstructured":"Rida, M. et al. A convenient method for the synthesis of 1,5-benzodiazepin-2-one. Open. Org. Chem. J. 2, 83\u201387 (2014).","journal-title":"Open. Org. Chem. J."},{"key":"97786_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser, M. J. et al. Relating protein Pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197\u2013206 (2007).","journal-title":"Nat. Biotechnol."},{"key":"97786_CR46","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/ar800236t","volume":"42","author":"WL Jorgensen","year":"2009","unstructured":"Jorgensen, W. L. Efficient drug lead discovery and optimization. Acc. Chem. Res. 42, 724\u2013733 (2009).","journal-title":"Acc. Chem. Res."},{"key":"97786_CR47","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller, D. et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42, W32 (2014).","journal-title":"Nucleic Acids Res."},{"key":"97786_CR48","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"97786_CR49","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.bmcl.2014.03.002","volume":"24","author":"KA Mahmoud","year":"2014","unstructured":"Mahmoud, K. A. et al. Discovery of 4-anilino \u03b1-carbolines as novel Brk inhibitors. Bioorg. Med. Chem. Lett. 24, 1948\u20131951 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"97786_CR50","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1389450116666150316223655","volume":"17","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Targeting AMPK signaling pathway to overcome drug resistance for cancer therapy. Curr. Drug Targets. 17, 853\u2013864 (2016).","journal-title":"Curr. Drug Targets"},{"key":"97786_CR51","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbamcr.2019.03.013","volume":"1866","author":"F Chiarini","year":"2019","unstructured":"Chiarini, F., Evangelisti, C., Lattanzi, G., McCubrey, J. A. & Martelli, A. M. Advances in Understanding the mechanisms of evasive and innate resistance to mTOR Inhibition in cancer cells. Biochim. Biophys. Acta - Mol. Cell. Res. 1866, 1322\u20131337 (2019).","journal-title":"Biochim. Biophys. Acta - Mol. Cell. Res."},{"key":"97786_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1615\/CritRevOncog.2016016976","volume":"21","author":"AR Safa","year":"2016","unstructured":"Safa, A. R. Resistance to cell death and its modulation in cancer stem cells. Crit. Rev. Oncog. 21, 203\u2013219 (2016).","journal-title":"Crit. Rev. Oncog."},{"key":"97786_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1381612003400948","volume":"6","author":"JK Buolamwini","year":"2005","unstructured":"Buolamwini, J. K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6, 379\u2013392 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"97786_CR54","doi-asserted-by":"publisher","first-page":"154854","DOI":"10.1016\/j.prp.2023.154854","volume":"251","author":"SG Almalki","year":"2023","unstructured":"Almalki, S. G. The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors. Pathol. - Res. Pract. 251, 154854 (2023).","journal-title":"Pathol. - Res. Pract."},{"key":"97786_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ijc.24064","volume":"124","author":"S Fulda","year":"2009","unstructured":"Fulda, S. Tumor resistance to apoptosis. Int. J. Cancer. 124, 511\u2013515 (2009).","journal-title":"Int. J. Cancer"},{"key":"97786_CR56","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1570180819666220922103109","volume":"21","author":"MT Muhammed","year":"2022","unstructured":"Muhammed, M. T., Aki-Yalcin, E. & Molecular Docking Principles, advances, and its applications in drug discovery. Lett. Drug Des. Discov. 21, 480\u2013495 (2022).","journal-title":"Lett. Drug Des. Discov"},{"key":"97786_CR57","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts, K. et al. Structural analysis of the mechanism of Inhibition and allosteric activation of the kinase domain of HER2 protein. J. Biol. Chem. 286, 18756\u201318765 (2011).","journal-title":"J. Biol. Chem."},{"key":"97786_CR58","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1021\/jm2008634","volume":"54","author":"T Ishikawa","year":"2011","unstructured":"Ishikawa, T. et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)\/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. J. Med. Chem. 54, 8030\u20138050 (2011).","journal-title":"J. Med. Chem."},{"key":"97786_CR59","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.celrep.2020.01.091","volume":"30","author":"Y Song","year":"2020","unstructured":"Song, Y. et al. Mechanism of crosstalk between the LSD1 demethylase and HDAC1 deacetylase in the CoREST complex. Cell. Rep. 30, 2699\u20132711e8 (2020).","journal-title":"Cell. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97786-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T11:02:35Z","timestamp":1744974155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97786-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97786-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13424"}}